Adiposity and cognitive decline: Underlying mechanisms

Journal of Alzheimer's Disease

Volumn 30, Issue SUPPL.2, 2012, Pages

  Gustafson, Deborah R ^a,b,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c Section for NeuroEpidemiology   (United States)

Author keywords

Adiponectin; adipose; all cognitive disorders dementia; Alzheimer's disease; endocrine; epidemiology; ghrelin; leptin; risk factors

Indexed keywords

ACARBOSE; ADENOSINE TRIPHOSPHATE; ADIPONECTIN; AMYLIN; CHLORPROPAMIDE; CYTOKINE; GHRELIN; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LEPTIN; METFORMIN; MIGLITOL; NERVE GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; REPAGLINIDE; RESISTIN; RETINOL BINDING PROTEIN; SCATTER FACTOR; TOLAZAMIDE; TOLBUTAMIDE; UNCOUPLING PROTEIN 1;

AGING; ALZHEIMER DISEASE; BODY COMPOSITION; BODY MASS; BRAIN FUNCTION; BRAIN REGION; BROWN ADIPOSE TISSUE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; COGNITIVE RESERVE; DEMENTIA; DISEASE ASSOCIATION; DRUG MECHANISM; FATTY ACID OXIDATION; HORMONE ACTION; HUMAN; MESENCHYMAL STEM CELL; MITOCHONDRIAL MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TISSUE REGENERATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

EID: 84862977266     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120487     Document Type: Review

References (117)

1. Gustafson D (2006) Adiposity indices and dementia. Lancet Neurol 5, 713-720. (Pubitemid 44062421)
2. Gustafson D (2008) A life course of adiposity and dementia. Eur J Pharmacol 585, 163-175.
3. Gustafson D, Skoog I (2009) Control of vascular risk factors. In: Vascular cognitive impairment in clinical practice, Wahlund L-O, Erkinjuntti T, Gauthier S, ed. Cambridge University Press, London, pp. 220-234.
4. Anstey KJ, Cherbuin N, Budge M, Young J (2011) Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obes Rev 12, e426-e437.
5. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K (2007) Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res 4, 103-109. (Pubitemid 46557496)
6. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057-1064.
7. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr, Luchsinger JA (2009) Midlife and late-life obesity and the risk of dementia: Cardiovascular health study. Arch Neurol 66, 336-342.
8. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissi-nen A (2005) Obesity and vascular risk factorsat midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62, 1556-1560. (Pubitemid 41434560)
9. Gustafson DR, Bäckman K, Waern M, Ö stling S, Guo X, Zandi PP, Mielke MM, Bengtsson C, Skoog I (2009) Adiposity indicators and dementia over 32 years in Sweden. Neurology 73, 1559-1566.
10. Gustafson D, Bäckman K, Joas E, Waern M, Ö stling S, Guo X, Skoog I (2012) A 37-year longitudinal follow-up of body mass index and dementia in women. J Alzheimers Dis 28, 162-171.
11. Gustafson DR, Bäckman K, Waern M, Ö stling S, Guo XX, Zandi P, Mielke MM, Bengtsson C, Skoog I (2009) Adiposity indicators and dementia over 32 years in Sweden. Neurology 73, 1559-1566.
12. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA (2005) Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897. (Pubitemid 41362136)
13. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC (1996) Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 44, 1147-1152. (Pubitemid 26338826)
14. Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, White LR, Launer LJ (2005) A 32-year prospective studyofchange in body weight and incident dementia: The Honolulu-Asia Aging Study. Arch Neurol 62, 55-60. (Pubitemid 40105036)
15. Gustafson DR, Rothenberg E, Blennow K, Steen B, Skoog I (2003) An 18-year follow up of overweight and risk for Alzheimer's disease. Arch Intern Med 163, 1524-1528. (Pubitemid 36835095)
16. Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA (2006) Vascular risk factors for incident Alzheimer disease and vascular dementia: The Cache County study. Alzheimer Dis Assoc Disord 20, 93-100. (Pubitemid 44305908)
17. Gustafson DR, Mazzuco S, Ongaro F, Antuono P, For-loni GL, Albani D, Gajo GB, Durante E, Caberlotto L, Zanardo A, Siculi M, Gallucci M (2011) Body Mass index, cognition, disability, APOE genotype, and mortality: The "Treviso Longeva" study. Am J Geriatric Psychiatry, doi: 10.1097/JGP. 0b013e31823031a4.
18. Thomas DR (2007) Loss of skeletal muscle mass ins aging: Examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26, 389-399. (Pubitemid 47091483)
19. Prunet-Marcassus B, Cousin B, Caton D, André M, Pénicaud L, Casteilla L (2006) From heterogeneity to plasticity in adipose tissues: Site-specific differences. Exp Cell Res 312, 727-736.
20. Shen W, Wang Z, Punyanita M, Lei J, Sinav A, Kral JG, Imielinska C, Ross R, Heymsfield SB (2003) Adipose tissue quantification by imaging methods: A proposed classification. Obes Res 11, 5-16. (Pubitemid 41137532)
21. McGavock JM, Victor RG, Unger RH, Szczepaniak LS (2006) Adiposity of the heart, revisited. Ann Intern Med 144, 517-524. (Pubitemid 46780675)
22. Kawai M, Devlin MJ, Rosen CJ (2009) Fat targets for skeletal health. Nat Rev Rheumatol 5, 365-372.
23. Enerbäck S (2010) Brown adipose tissue in humans. Int J Obes 34 (Suppl 1) , S43-S46.
24. Yarak S, Okamoto OK (2010) Human adipose-derived stem cells: Current challenges and clinical perspectives. An Bras Dermatol 85, 647-656.
25. Enerbäck S (2010) Human brown adipose tissue. Cell Metab 11, 248-252.
26. Ravussin E, Galgani JE (2011) The implication of brown adipose tissue for humans. Annu Rev Nutr 31, 33-47.
27. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
28. Lecoultre V, Ravussin E (2011) Brown adipose tissue and aging. Curr Opin Clin Nutr Metab Care 14, 1-6.
29. Rousset S, Alves-Guerra MC, Mozo J, Miroux B, Cassard-Doulcier AM, Bouillaud F, Ricquier D (2004) The biology of mitochondrial uncoupling proteins. Diabetes 53 (Suppl 1) , S130-S135. (Pubitemid 38168705)
30. Huffman DM, Barzilai N (2010) Contribution of adipose tissue to health span and longevity. Interdiscip Top Gerontol 37, 1-19.
31. Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13, 1-7.
32. Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293, E444-E452. (Pubitemid 47205086)
33. Nedergaard J, Cannon B (2010) The changed metabolic world with human brown adipose tissue: Therapeutic visions. Cell Metab 11, 268-272.
34. Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerback S, Nuutila P (2009) Functional brown adipose tissue in healthy adults. New Engl J Med 360, 1518-1525.
35. Yang K, Walker JM (2010) Adipose tissue protocols, Humana Press, New York, NY, p. 227.
36. Murray RK, Granner DK, Mayes PA, Rodwell VW (2003) Harper's Illustrated Biochemistry, Lange Medical Books/McGraw Hill, New York, NY, pp. 92-148.
37. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H, Tempst P, Rudnicki MA, Beier DR, Spiegelman BM (2008) PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961-967.
38. Mattson MP (2010) Perspective: Does brown fat protect against diseases of aging? Ageing Res Rev 9, 69-76.
39. Ducharme NA, Bickel PE (2008) Lipid droplets in lipogen-esis and lipolysis. Endocrinology 149, 942-949.
40. Pfannenberg C, Werner MK, Ripkens S, Stef I, Deckert A, Schmadl M, Reimold M, Haring HU, Claussen CD, Stefan N (2010) Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes 59, 1789-1793.
41. Ouellet V, Routhier-Labadie A, Bellemare W, Lakhal-Chaieb L, Turcotte E, Carpentier AC, Richard D (2011) Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J Clin Endocrinol Metab 96, 192-199.
42. Nedergaard J, Bengtsson T, Cannon B (2010) Three years with adult human brown adipose tissue. Ann N Y Acad Sci 1212, E20-E36.
43. Jacene HA, Cohade CC, Zhang Z, Wahl RL (2011) The relationship between patients' serum glucose levels and metabolically active brown adipose tissue detected by PET/CT. Mol Imaging Biol 13, 1278-1283.
44. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR (2009) Identification and importance of brown adipose tissue in adult humans. New Engl J Med 360, 1509-1517.
45. Chapman IM (2010) Obesity paradox during aging. Inter-discip Top Gerontol 37, 20-36.
46. St-Onge MP, Gallagher D (2010) Body composition changes with aging: The causeorthe resultofalterationsinmetabolic rate and macronutrient oxidation? Nutrition 26, 152-155.
47. Davidson TL, Kanoski SE, Walls EK, Jarrard LE (2005) Memory inhibition and energy regulation. Physiol Behav 86, 731-746. (Pubitemid 41728990)
48. Harvey J, Shanley LJ, O'Malley D, Irving AJ (2005) Lep-tin: A potential cognitive enhancer? Biochem Soc Trans 33, 1029-1032.
49. Kishi T, Elmquist JK (2005) Body weightisregulatedby the brain: A link between feeding and emotion. Mol Psychiatry 10, 132-146. (Pubitemid 40188510)
50. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10, 524-529. (Pubitemid 38667912)
51. Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N (2004) Obesity-related leptin regulates Alzheimer's Abeta. FASEB J 18, 1870-1878. (Pubitemid 39602272)
52. Olsson T, Nasman B, Rasmuson S, Ahren B (1998) Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease. Biol Psychiatry 44, 374-376. (Pubitemid 28432651)
53. Power DA, Noel J, Collins R, O'Neill D (2001) Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord 12, 167-170. (Pubitemid 32149724)
54. Mielke MM, Zandi PP, Shao H, Waern M, Ostling S, Guo X, Bjorkelund C, Lissner L, Skoog I, Gustafson DR (2010) The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology 75, 1888-1895.
55. Stewart R, White LR, Xue QL, Launer LJ (2007) Twenty-six-year change in total cholesterol levels and incident dementia: The Honolulu-Asia Aging Study. Arch Neurol 64, 103-107. (Pubitemid 46072431)
56. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145. (Pubitemid 126512042)
57. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ (2009) Change in blood pressure and incident dementia: A 32-year prospective study. Hypertension 54, 233-240.
58. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358, 2545-2559. (Pubitemid 351831356)
59. Duvnjak L, Duvnjak M (2009) The metabolic syndrome -an ongoing story. J Physiol Pharmacol 60 (Suppl 7) , 19-24.
60. Zhang Y, Proenca R, Maffel M, Barone M, Leopold L, Fried-man J (1994) Positional cloningofthe mouseobesegene and its human homologue. Nature 372, 425-432. (Pubitemid 24365442)
61. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al. (1995) Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 1155-1161.
62. Banks W (2003) Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations. Curr Pharm Des 9, 801-809. (Pubitemid 36367602)
63. Friedman J, Halaas L (1998) Leptin and the regulation of body weight in mammals. Nature 22, 763-770. (Pubitemid 28485436)
64. Lissner L, Karlsson C, Lindroos AK, Sjostrom L, Carlsson B, Carlsson L, Bengtsson C (1999) Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women. Obes Res 7, 150-154. (Pubitemid 129710572)
65. Bluher S, Mantzoros CS (2009) Leptin in humans: Lessons from translational research. Am J Clin Nutr 89, 991S-997S.
66. Abizaid A, Horvath TL (2008) Brain circuits regulating energy homeostasis. Regul Pept 149, 3-10.
67. Oomura Y, Aou S, Fukunaga K (2010) Prandial increase of leptin in the brain activates spatial learning and memory. Pathophysiology 17, 119-127.
68. Hill JW, Elias CF, Fukuda M, Williams KW, Berglund ED, Holland WL, Cho YR, Chuang JC, Xu Y, Choi M, Lauzon D, Lee CE, Coppari R, Richardson JA, Zigman JM, Chua S, Scherer PE, Lowell BB, Bruning JC, Elmquist JK (2010) Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab 11, 286-297.
69. Williams KW, Margatho LO, Lee CE, Choi M, Lee S, Scott MM, Elias CF, Elmquist JK (2010) Segregation of acute leptin and insulin effects in distinct populations of arcuate proopiomelanocortin neurons. J Neurosci 30, 2472-2479.
70. Gustafson D, Karlsson C, Skoog I, Rosengren L, Lissner L, Blennow K (2007) Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J Intern Med 262, 643-650. (Pubitemid 350135196)
71. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S (2009) Association of plasma leptin levels with incident Alzheimer's disease and MRI measures of brain aging. JAMA 302, 2565-2572.
72. Holden KF, Lindquist K, Tylavsky FA, Rosano C, Harris TB, Yaffe K (2009) Serum leptin level and cognition in the elderly: Findings from the Health ABC Study. Neurobiol Aging 30, 1483-1489.
73. Carro EM (2009) Therapeutic approaches of leptin in Alzheimer's disease. Recent Pat CNS Drug Discov 4, 200-208.
74. Enriori PJ, Sinnayah P, Simonds SE, Garcia Rudaz C, Cowley MA (2011) Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J Neurosci 31, 12189-12197.
75. Kanoski SE, Hayes MR, Greenwald HS, Fortin SM, Gianessi CA, Gilbert JR, Grill HJ (2011) Hippocampal lep-tin signaling reduces food intake and modulates food-related memory processing. Neuropsychopharmacology 36, 1859-1870.
76. Sinha M, Songer T, Xiao Q, Sloan JH, Wang J, Ji S, Alborn WE, Davis RA, Swarbrick MM, Stanhope KL, Wolfe BM, Havel PJ, Schraw T, Konrad RJ, Scherer PE, Mistry JS (2007) Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA. Clin Chem 53, 2144-2151. (Pubitemid 350197298)
77. Roberts RO, Geda YE, Knopman DS, Boeve BF, Chris-tianson TJ, Pankratz VS, Kullo IJ, Tangalos EG, Ivnik RJ, Petersen RC (2009) Assocation of C-reative protein with mild cognitive impairment. Alzheimers Dement 5, 398-405.
78. Ban Y, Watanabe T, Miyazaki A, Nakano Y, Tobe T, Idei T, Iguchi T, Ban Y, Katagiri T (2007) Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia. Atherosclerosis 195, 153-159. (Pubitemid 47561931)
79. Une K, Takei YA, Tomita N, Asamura T, Ohrui T, Furukawa K, Arai H (2011) Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease. Eur J Neurol 18, 1006-1009.
80. Drolet R, Bélanger C, Fortier M, Huot C, Mailloux J, Légaré D, Tchernof A (2008) Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity (Silver Spring) 17, 424-430.
81. Benchenane K, Berezowski V, Ali C, Fernandez-Monreal M, Lopez-Atalaya JP, Brillault J, Chuquet J, Nouvelot A, MacKenzie ET, Bu G, Cecchelli R, Touzani O, Vivien D (2005) Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111, 2241-2249. (Pubitemid 40632441)
82. Medina MG, Ledesma MD, Dominguez JE, Medina M, Zafra D, Alameda F, Dotti CG, Navarro P (2005) Tissueplas-minogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation. EMBO J 24, 1706-1716. (Pubitemid 40704981)
83. Jung C, Fritzenwanger M, Fischer N, Figulla HR (2009) Hepatocyte growth factor is elevated in obese adolescents. J Pediatr Endocrinol Metab 22, 645-651.
84. Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS, Steinberg HO, March KL, Considine RV (2006) Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab 291, E843-E848. (Pubitemid 44484928)
85. Fenton H, Finch PW, Rubin JS, Rosenberg JM, Taylor WG, Kuo-Leblanc V, Rodriguez-Wolf M, Baird A, Schipper HM, Stopa EG (1998) Hepatocyte growth factor (HGF/SF) in Alzheimer's disease. Brain Res 779, 262-270. (Pubitemid 28039960)
86. Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D, Fazio S, Linton MF, Zheng W, Shu XO (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 16, 2464-2470. (Pubitemid 351196382)
87. Jung SM, Lee K, Lee JW, Namkoong H, Kim HK, Kim S, Na HR, Ha SA, Kim JR, Ko J, Kim JW (2008) Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: Candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease. Neurosci Lett 436, 153-157.
88. Lin L, Saha PK, Ma X, Henshaw IO, Shao L, Chang BH, Buras ED, Tong Q, Chan L, McGuinness OP, Sun Y (2011) Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 10, 996-1010.
89. Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svens-son L, Engel J (2006) Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: Implications for its involvement in brain reward. Addict Biol 11, 45-54. (Pubitemid 46696736)
90. Baatar D, Patel K, Taub DD (2011) The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 340, 44-58.
91. Gahete MD, Rubio A, Cordoba-Chacon J, Gracia-Navarro F, Kineman RD, Avila J, Luque RM, Castano JP (2010) Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. J Alzheimers Dis 22, 819-828.
92. Ranganath LR (2008) The entero-insular axis: Implications for human metabolism. Clin Chem Lab Med 46, 43-56.
93. Lutz TA (2011) Control of energy homeostasis by amylin. Cell Mol Life Sci, doi: 10.1007/s00018-011-0905-1.
94. Tyas SL, Snowdon DA, Desrosiers MF, Riley KP, Markes-bery WR (2007) Healthy ageing in the Nun Study:Definition and neuropathologic correlates. Age Ageing 36, 650-655. (Pubitemid 350258975)
95. Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28, 202-208. (Pubitemid 40445527)
96. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.
97. Gustafson DR, Karlsson C, Skoog I, Rosengren L, Lissner L, Blennow K (2007) Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J Intern Med 262, 643-650. (Pubitemid 350135196)
98. Gustafson D, Lissner L, Bengtsson C, Björkelund C, Skoog I (2004) A24-year follow-upofbody mass index and cerebral atrophy. Neurology 63, 1876-1881. (Pubitemid 39532384)
99. Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corn-eveaux JJ, Stephan DA, Decarli CS, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM (2010) Acommonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A 107, 8404-8409.
100. Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA (2006) Brain abnormalities in human obesity: A voxel-based morphometric study. Neuroimage 31, 1419-1425. (Pubitemid 43949229)
101. Gustafson D, Steen B, Skoog I (2004) Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Intl J Psychogeriatrics 16, 327-336. (Pubitemid 39441496)
102. Vidoni ED, Townley RA, Honea RA, Burns JM (2011) Alzheimer disease biomarkers are associated with body mass index. Neurology 77, 1913-1920.
103. Lee YH, Tharp WG, Maple RL, Nair S, Permana PA, Pratley RE (2008) Amyloid precursor protein expression is upreg-ulated in adipocytes in obesity. Obesity (Silver Spring) 16, 1493-1500. (Pubitemid 351915132)
104. Dickstein DL, Walsh J, Brautigam H, Stockton SD, Gandy S, Hof PR (2010) Roles of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med 77, 82-102.
105. Bush AI, Beyreuther K, Masters CL (1993) The beta A4 amyloid protein precursor in human circulation. Ann N Y Acad Sci 695, 175-182. (Pubitemid 23348257)
106. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 97, 12735-12740.
107. Bray GA, Popkin BM (1998) Dietary fat intake does affect obesity! Am J Clin Nutr 68, 1157-1173. (Pubitemid 28550944)
108. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
109. Zade D, Beiser A, McGlinchey R, Au R, Seshadri S, Palumbo C, Wolf PA, Decarli C, Milberg W (2011) Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure. J Stroke Cerebrovasc Dis, doi:10.1016/j.jstrokecerebrovasdis. 2011.06.020.
110. Keller L, Xu W, Wang HX, Winblad B, Fratiglioni L, Graff C (2011) The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: A prospective cohort study. J Alzheimers Dis 23, 461-469.
111. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O'Rahilly S, Schofield CJ (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethy-lase. Science 318, 1469-1472. (Pubitemid 350208961)
112. Ferguson LR (2008) Dissecting the nutrigenomics, diabetes, and gastrointestinal disease interface: From risk assessment to health intervention. OMICS 12, 237-244. (Pubitemid 352773937)
113. Tau GZ, Peterson BS (2010) Normal development of brain circuits. Neuropsychopharmacology 35, 147-168.
114. Barlett HL, Puhl SM, Hodgson JL, Buskirk ER (1991) Fat-free mass in relation to stature: Ratios of fat-free mass to height in children, adults, and elderly subjects. Am J Clin Nutr 53, 1112-1116.
115. Force NOT (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidenc report. Obes Res 6, 51S-209S.
116. Zhu S, Heshka S, Wang Z, Shen W, Allison DB, Ross R, Heymsfield SB (2004) Combination of BMI and waist circumference for identifying cardiovascular risk factors in Whites. Obes Res 12, 633-645. (Pubitemid 41132506)
117. Gustafson D (2010) Adiposity hormones and dementia. J Neurosci 299, 30-34.